Divis Laboratories Ltd | DIVI - Ebit

Stock Price
6,071.00
Daily Change
-211.00 -3.36%
Monthly
-1.28%
Yearly
7.06%
Q1 Forecast
5,952.62

Divis Laboratories Ltd reported INR7.72B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Aurobindo Pharma INR 12.43B 1.49B Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lupin INR 18.97B 757M Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025